Tag: StJohnsWort
	St. John’s wort: A flowering shrub (Hypericum perforatum) whose flowers and leaves are used most commonly for depression and menopausal symptoms.
Articles
Studies
- 
	 438P Antidepressants/anxiolytics and breast cancer treatment: The case of drug-drug interactions
	 	 Cite
	 Burger D, Nijboer L, Dontje A, Kuip E, Timmer-Bonte J, van Erp N. 438P Antidepressants/anxiolytics and breast cancer treatment: The case of drug-drug interactions. ESMO Open. Elsevier BV; 2025; 10:105010 10.1016/j.esmoop.2025.105010
 - 
	 The application of antidepressant drugs in cancer treatment
	 	 Cite
	 Zheng Y, Chang X, Huang Y, He D. The application of antidepressant drugs in cancer treatment. Biomedicine & Pharmacotherapy. Elsevier BV; 2023; 157:113985 10.1016/j.biopha.2022.113985
 - 
	 Herb–Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements
	 	 Cite
	 Annemarie A, Renner B. Herb–Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements. Journal of Clinical Medicine. MDPI AG; 2022; 11:1567 10.3390/jcm11061567
 - 
	 Alternative and Non-Hormonal treatments to symptoms of Menopause
	 	 Cite
	 Djapardy V, Panay N. Alternative and Non-Hormonal treatments to symptoms of Menopause. Best Practice & Research Clinical Obstetrics & Gynaecology. Elsevier BV; 2021; 10.1016/j.bpobgyn.2021.09.012
 - 
	 Revisiting the Anticancer Drug–Food Interactions
	 	 Cite
	 Gacche RN. Revisiting the Anticancer Drug–Food Interactions. Dietary Research and Cancer. Springer Singapore; 2021;:113-120 10.1007/978-981-16-6050-4_11
 - 
	 Herb–Drug Interactions: Worlds Intersect with the Patient at the Center
	 	 Cite
	 Babos MB, Heinan M, Redmond L, Moiz F, Souza-Peres JV, Samuels V, et al. Herb–Drug Interactions: Worlds Intersect with the Patient at the Center. Medicines. MDPI AG; 2021; 8:44 10.3390/medicines8080044
 - 
	 St. John’s Wort Suppresses Growth in Triple-Negative Breast Cancer Cell Line MDA-MB-231 by Inducing Prodeath Autophagy and Apoptosis
	 	 Cite
	 You M, Lee Y, Kim H, Kook JH, Kim H. St. John’s Wort Suppresses Growth in Triple-Negative Breast Cancer Cell Line MDA-MB-231 by Inducing Prodeath Autophagy and Apoptosis. Nutrients. MDPI AG; 2020; 12:3175 10.3390/nu12103175
 - 
	 Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings
	 	 Cite
	 Fasinu PS, Rapp GK. Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings. Frontiers in Oncology. Frontiers Media SA; 2019; 9 10.3389/fonc.2019.01356
 - 
	 St. John’s Wort Regulates Proliferation and Apoptosis in MCF-7 Human Breast Cancer Cells by Inhibiting AMPK/mTOR and Activating the Mitochondrial Pathway
	 	 Cite
	 You M, Kim H, Kook J, Kim H. St. John’s Wort Regulates Proliferation and Apoptosis in MCF-7 Human Breast Cancer Cells by Inhibiting AMPK/mTOR and Activating the Mitochondrial Pathway. International Journal of Molecular Sciences. MDPI AG; 2018; 19:966 10.3390/ijms19040966
 - 
	 Herbal Medications in Cardiovascular Medicine
	 	 Cite
	 Liperoti R, Vetrano DL, Bernabei R, Onder G. Herbal Medications in Cardiovascular Medicine. Journal of the American College of Cardiology. Elsevier BV; 2017; 69:1188-1199 10.1016/j.jacc.2016.11.078
 - 
	 MDR- and CYP3A4-mediated drug–herbal interactions
	 	 Cite
	 Pal D, Mitra AK. MDR- and CYP3A4-mediated drug–herbal interactions. Life Sciences. Elsevier BV; 2006; 78:2131-2145 10.1016/j.lfs.2005.12.010
 - 
	 The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy
	 	 Cite
	 Sweet E, Dowd F, Zhou M, Standish LJ, Andersen MR. The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2016; 2016:1-8 10.1155/2016/4382687
 - 
	 In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products
	 	 Cite
	 Foster B, Vandenhoek S, Hana J, Krantis A, Akhtar M, Bryan M, et al. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine. Elsevier BV; 2003; 10:334-342 10.1078/094471103322004839
 - 
	 Herb‐Drug Interactions in Oncology: Focus on Mechanisms of Induction
	 	 Cite
	 Meijerman I, Beijnen JH, Schellens JH. Herb‐Drug Interactions in Oncology: Focus on Mechanisms of Induction. The Oncologist. Wiley; 2006; 11:742-752 10.1634/theoncologist.11-7-742
 - 
	 Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations
	 	 Cite
	 L’Espérance S, Frenette S, Dionne A, Dionne J. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations. Supportive Care in Cancer. Springer Science and Business Media LLC; 2013; 21:1461-1474 10.1007/s00520-013-1732-8
 - 
	 Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer
	 	 Cite
	 Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer. The Journal of Alternative and Complementary Medicine. Mary Ann Liebert Inc; 2013; 19:714-720 10.1089/acm.2012.0295
 - 
	 The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study
	 	 Cite
	 Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study. BMC Cancer. Springer Science and Business Media LLC; 2011; 11 10.1186/1471-2407-11-222
 - 
	 Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
	 	 Cite
	 Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1696-1708 10.1158/1055-9965.epi-10-0318